Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Vegfa protects the glomerular microvasculature in diabetes.

Sivaskandarajah GA, Jeansson M, Maezawa Y, Eremina V, Baelde HJ, Quaggin SE.

Diabetes. 2012 Nov;61(11):2958-66. doi: 10.2337/db11-1655.

PMID:
23093658
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

Kidney Int. 2005 Oct;68(4):1583-9.

PMID:
16164635
[PubMed - indexed for MEDLINE]
3.

eNOS deficiency predisposes podocytes to injury in diabetes.

Yuen DA, Stead BE, Zhang Y, White KE, Kabir MG, Thai K, Advani SL, Connelly KA, Takano T, Zhu L, Cox AJ, Kelly DJ, Gibson IW, Takahashi T, Harris RC, Advani A.

J Am Soc Nephrol. 2012 Nov;23(11):1810-23. doi: 10.1681/ASN.2011121170. Epub 2012 Sep 20.

PMID:
22997257
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.

Wang Y, Heilig K, Saunders T, Minto A, Deb DK, Chang A, Brosius F, Monteiro C, Heilig CW.

Am J Physiol Renal Physiol. 2010 Jul;299(1):F99-F111. doi: 10.1152/ajprenal.00466.2009. Epub 2010 Apr 7.

PMID:
20375117
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.

Mima A, Kitada M, Geraldes P, Li Q, Matsumoto M, Mizutani K, Qi W, Li C, Leitges M, Rask-Madsen C, King GL.

FASEB J. 2012 Jul;26(7):2963-74. doi: 10.1096/fj.11-202994. Epub 2012 Apr 12.

PMID:
22499584
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.

Wang S, Li Y, Zhao J, Zhang J, Huang Y.

Biol Blood Marrow Transplant. 2013 Apr;19(4):538-46. doi: 10.1016/j.bbmt.2013.01.001. Epub 2013 Jan 4.

PMID:
23295166
[PubMed - indexed for MEDLINE]
7.

Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.

Ku CH, White KE, Dei Cas A, Hayward A, Webster Z, Bilous R, Marshall S, Viberti G, Gnudi L.

Diabetes. 2008 Oct;57(10):2824-33. doi: 10.2337/db08-0647. Epub 2008 Jul 22.

PMID:
18647955
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.

Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Corat MA, Zeier M, Blessing E, Oh J, Gerlitz B, Berg DT, Grinnell BW, Chavakis T, Esmon CT, Weiler H, Bierhaus A, Nawroth PP.

Nat Med. 2007 Nov;13(11):1349-58. Epub 2007 Nov 4.

PMID:
17982464
[PubMed - indexed for MEDLINE]
9.

Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.

Veron D, Bertuccio CA, Marlier A, Reidy K, Garcia AM, Jimenez J, Velazquez H, Kashgarian M, Moeckel GW, Tufro A.

Diabetologia. 2011 May;54(5):1227-41. doi: 10.1007/s00125-010-2034-z. Epub 2011 Feb 12.

PMID:
21318407
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.

Tarabra E, Giunti S, Barutta F, Salvidio G, Burt D, Deferrari G, Gambino R, Vergola D, Pinach S, Perin PC, Camussi G, Gruden G.

Diabetes. 2009 Sep;58(9):2109-18. doi: 10.2337/db08-0895. Epub 2009 Jul 8.

PMID:
19587356
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.

Gödel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S, Debreczeni-Mór A, Lindenmeyer MT, Rastaldi MP, Hartleben G, Wiech T, Fornoni A, Nelson RG, Kretzler M, Wanke R, Pavenstädt H, Kerjaschki D, Cohen CD, Hall MN, Rüegg MA, Inoki K, Walz G, Huber TB.

J Clin Invest. 2011 Jun;121(6):2197-209. doi: 10.1172/JCI44774. Epub 2011 May 23.

PMID:
21606591
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.

Kim DK, Nam BY, Li JJ, Park JT, Lee SH, Kim DH, Kim JY, Kang HY, Han SH, Yoo TH, Han DS, Kang SW.

Diabetologia. 2012 Apr;55(4):1205-17. doi: 10.1007/s00125-012-2467-7. Epub 2012 Feb 4.

PMID:
22311416
[PubMed - indexed for MEDLINE]
13.

Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.

Stieger N, Worthmann K, Teng B, Engeli S, Das AM, Haller H, Schiffer M.

Metabolism. 2012 Aug;61(8):1073-86. doi: 10.1016/j.metabol.2011.12.003. Epub 2012 Feb 24.

PMID:
22365040
[PubMed - indexed for MEDLINE]
14.

Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.

Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Göke B, Wolf E, Wanke R.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F819-29. doi: 10.1152/ajprenal.90665.2008. Epub 2009 Feb 11.

PMID:
19211686
[PubMed - indexed for MEDLINE]
Free Article
15.

Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.

Zheng S, Carlson EC, Yang L, Kralik PM, Huang Y, Epstein PN.

J Am Soc Nephrol. 2008 Nov;19(11):2077-85. doi: 10.1681/ASN.2007080967. Epub 2008 Jul 16.

PMID:
18632844
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.

Yamaguchi Y, Iwano M, Suzuki D, Nakatani K, Kimura K, Harada K, Kubo A, Akai Y, Toyoda M, Kanauchi M, Neilson EG, Saito Y.

Am J Kidney Dis. 2009 Oct;54(4):653-64. doi: 10.1053/j.ajkd.2009.05.009. Epub 2009 Jul 17.

PMID:
19615802
[PubMed - indexed for MEDLINE]
17.

Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.

Veron D, Reidy KJ, Bertuccio C, Teichman J, Villegas G, Jimenez J, Shen W, Kopp JB, Thomas DB, Tufro A.

Kidney Int. 2010 Jun;77(11):989-99. doi: 10.1038/ki.2010.64. Epub 2010 Mar 10.

PMID:
20375978
[PubMed - indexed for MEDLINE]
18.

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.

Ziyadeh FN, Wolf G.

Curr Diabetes Rev. 2008 Feb;4(1):39-45. Review.

PMID:
18220694
[PubMed - indexed for MEDLINE]
19.

Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CP.

Kidney Int. 2006 May;69(9):1654-61.

PMID:
16541023
[PubMed - indexed for MEDLINE]
20.

Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice.

Nadarajah R, Milagres R, Dilauro M, Gutsol A, Xiao F, Zimpelmann J, Kennedy C, Wysocki J, Batlle D, Burns KD.

Kidney Int. 2012 Aug;82(3):292-303. doi: 10.1038/ki.2012.83. Epub 2012 Apr 4.

PMID:
22475818
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk